AAAAAA

   
Results: 1-11 |
Results: 11
Indinavir crystallization around the loop of Henle: Experimental evidence
Authors: Dieleman, JP Salahuddin, S Hsu, YS Burger, DM Gyssens, IC Sturkenboom, MCJM Stricker, BHC Kok, DJ
Citation: Jp. Dieleman et al., Indinavir crystallization around the loop of Henle: Experimental evidence, J ACQ IMM D, 28(1), 2001, pp. 9-13
Quality measures of antimicrobial drug use
Authors: Gyssens, IC
Citation: Ic. Gyssens, Quality measures of antimicrobial drug use, INT J ANT A, 17(1), 2001, pp. 9-19
Pharmacokinetics of sequential intravenous and enteral fluconazole in critically ill surgical patients with invasive mycoses and compromised gastro-intestinal function
Authors: Buijk, SLCE Gyssens, IC Mouton, JW Verbrugh, HA Touw, DJ Bruining, HA
Citation: Slce. Buijk et al., Pharmacokinetics of sequential intravenous and enteral fluconazole in critically ill surgical patients with invasive mycoses and compromised gastro-intestinal function, INTEN CAR M, 27(1), 2001, pp. 115-121
Is indinavir crystalluria an indicator for indinavir stone formation?
Authors: Salahuddin, S Hsu, YS Buchholz, NP Dieleman, JP Gyssens, IC Kok, DJ
Citation: S. Salahuddin et al., Is indinavir crystalluria an indicator for indinavir stone formation?, AIDS, 15(8), 2001, pp. 1079-1080
Indinavir-associated asymptomatic nephrolithiasis and renal cortex atrophyin two HIV-1 infected children
Authors: van Rossum, AMC Dieleman, JP Fraaij, PLA Cransberg, K Hartwig, NG Gyssens, IC de Groot, R
Citation: Amc. Van Rossum et al., Indinavir-associated asymptomatic nephrolithiasis and renal cortex atrophyin two HIV-1 infected children, AIDS, 15(13), 2001, pp. 1745-1747
In vivo efficacy of trovafloxacin against Bacteroides fragilis in mixed infection with either Escherichia coli or a vancomycin-resistant strain of Enterococcus faecium in an established-abscess murine model
Authors: Stearne, LET Gyssens, IC Goessens, WHF Mouton, JW Oyen, WJG Van der Meer, JWM Verbrugh, HA
Citation: Let. Stearne et al., In vivo efficacy of trovafloxacin against Bacteroides fragilis in mixed infection with either Escherichia coli or a vancomycin-resistant strain of Enterococcus faecium in an established-abscess murine model, ANTIM AG CH, 45(5), 2001, pp. 1394-1401
In vitro activity of trovafloxacin against Bacteroides fragilis in mixed culture with either Escherichia coli or a vancomycin-resistant strain of Enterococcus faecium determined by an anaerobic time-kill technique
Authors: Stearne, LET Kooi, C Goessens, WHF Bakker-Woudenberg, IAJM Gyssens, IC
Citation: Let. Stearne et al., In vitro activity of trovafloxacin against Bacteroides fragilis in mixed culture with either Escherichia coli or a vancomycin-resistant strain of Enterococcus faecium determined by an anaerobic time-kill technique, ANTIM AG CH, 45(1), 2001, pp. 243-251
Urological complaints in relation to indinavir plasma concentrations in HIV-infected patients
Authors: Dieleman, JP Gyssens, IC van der Ende, ME de Marie, S Burger, DM
Citation: Jp. Dieleman et al., Urological complaints in relation to indinavir plasma concentrations in HIV-infected patients, AIDS, 13(4), 1999, pp. 473-478
Substituting nevirapine for protease inhibitors because of intolerance
Authors: Dieleman, JP Gyssens, IC Sturkenboom, MJCM Niesters, HGM van der Ende, ME
Citation: Jp. Dieleman et al., Substituting nevirapine for protease inhibitors because of intolerance, AIDS, 13(11), 1999, pp. 1423-1424
Preventing postoperative infections - Current treatment recommendations
Authors: Gyssens, IC
Citation: Ic. Gyssens, Preventing postoperative infections - Current treatment recommendations, DRUGS, 57(2), 1999, pp. 175-185
How to optimize prescription of antimicrobial drugs
Authors: Gyssens, IC
Citation: Ic. Gyssens, How to optimize prescription of antimicrobial drugs, ACT CLIN B, 54(1), 1999, pp. 7-12
Risultati: 1-11 |